MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
11.39
-0.85
-6.94%
After Hours: 11.83 +0.44 +3.85% 19:03 12/05 EST
OPEN
12.22
PREV CLOSE
12.24
HIGH
12.29
LOW
11.38
VOLUME
50.59K
TURNOVER
--
52 WEEK HIGH
190.50
52 WEEK LOW
6.00
MARKET CAP
21.46M
P/E (TTM)
-0.1832
1D
5D
1M
3M
1Y
5Y
1D
BriaCell Unveils Promising Clinical Data at 2025 SABCS
TipRanks · 4d ago
BriaCell Therapeutics To Present Phase 2 Survival, And Phase 3 Biomarker Data Across Three Clinical Posters At 2025 SABCS
Benzinga · 4d ago
BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025
TipRanks · 4d ago
BriaCell announces publication with preliminary Phase 1b expansion cohort data
TipRanks · 5d ago
Weekly Report: what happened at BCTX last week (1124-1128)?
Weekly Report · 5d ago
BriaCell Therapeutics to Present Promising Clinical Data at SABCS 2025
TipRanks · 11/25 13:11
BriaCell Therapeutics To Highlight Phase 2 Safety And Efficacy Signals And Biomarker Findings In Both Phase 2 And Pivotal Phase 3 Studies At 2025 SABCS
Benzinga · 11/25 12:37
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
Barchart · 11/25 06:30
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.